Yu, Q.; Li, Z.; Liu, Y.; Luo, Y.; Fan, J.; Xie, P.; Cao, X.; Chen, X.; Wang, X.
Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database. Curr. Oncol. 2023, 30, 949-958.
https://doi.org/10.3390/curroncol30010072
AMA Style
Yu Q, Li Z, Liu Y, Luo Y, Fan J, Xie P, Cao X, Chen X, Wang X.
Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database. Current Oncology. 2023; 30(1):949-958.
https://doi.org/10.3390/curroncol30010072
Chicago/Turabian Style
Yu, Qiao, Zhigui Li, Yuqing Liu, Yichen Luo, Jingya Fan, Peijun Xie, Xiaoman Cao, Xingyu Chen, and Xiaodong Wang.
2023. "Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database" Current Oncology 30, no. 1: 949-958.
https://doi.org/10.3390/curroncol30010072
APA Style
Yu, Q., Li, Z., Liu, Y., Luo, Y., Fan, J., Xie, P., Cao, X., Chen, X., & Wang, X.
(2023). Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database. Current Oncology, 30(1), 949-958.
https://doi.org/10.3390/curroncol30010072
